Answers are grounded in this paper and cite their sources.
Blockade of the CD40 pathway with anti-CD40 mAb is immunosuppressive in a large animal, preclinical renal transplant model. The potential effect of this therapy on viral immune responses will be important to consider for the design of safe clinical trials.
No takes yet. Share an insight, caveat, or question.
Pearson et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: